Wood D - Search Results

1

Erlotinib plus gemcitabine in patients with unresectable pancreatic cancer and other solid tumors: phase IB trial.

Dragovich T, Huberman M, Von Hoff DD, Rowinsky EK, Nadler P, Wood D, Hamilton M, Hage G, Wolf J, Patnaik A. Dragovich T, et al. Among authors: wood d. Cancer Chemother Pharmacol. 2007 Jul;60(2):295-303. doi: 10.1007/s00280-006-0389-0. Epub 2006 Dec 6. Cancer Chemother Pharmacol. 2007. PMID: 17149608 Clinical Trial.

2

Phase I, pharmacokinetic, and biological study of erlotinib in combination with paclitaxel and carboplatin in patients with advanced solid tumors.

Patnaik A, Wood D, Tolcher AW, Hamilton M, Kreisberg JI, Hammond LA, Schwartz G, Beeram M, Hidalgo M, Mita MM, Wolf J, Nadler P, Rowinsky EK. Patnaik A, et al. Among authors: wood d. Clin Cancer Res. 2006 Dec 15;12(24):7406-13. doi: 10.1158/1078-0432.CCR-06-1886. Clin Cancer Res. 2006. PMID: 17189413 Clinical Trial.

3

First-in-human trial exploring safety, antitumor activity, and pharmacokinetics of Sym013, a recombinant pan-HER antibody mixture, in advanced epithelial malignancies.

Berlin J, Tolcher AW, Ding C, Whisenant JG, Horak ID, Wood DL, Nadler PI, Hansen UH, Lantto J, Skartved NJØ, Pedersen MW, Patnaik A. Berlin J, et al. Among authors: wood dl. Invest New Drugs. 2022 Jun;40(3):586-595. doi: 10.1007/s10637-022-01217-7. Epub 2022 Feb 3. Invest New Drugs. 2022. PMID: 35113285 Clinical Trial.

4

A phase I pharmacokinetic study of recombinant human tumor necrosis factor administered by a 5-day continuous infusion.

Mittelman A, Puccio C, Gafney E, Coombe N, Singh B, Wood D, Nadler P, Ahmed T, Arlin Z. Mittelman A, et al. Among authors: wood d. Invest New Drugs. 1992 Aug;10(3):183-90. doi: 10.1007/BF00877244. Invest New Drugs. 1992. PMID: 1428728 Clinical Trial.

5

Biologic response modulation by tumor necrosis factor alpha (TNF alpha) in a phase Ib trial in cancer patients.

Logan TF, Gooding WE, Whiteside TL, Ernstoff MS, Kaplan SS, Miketic L, Vlock DR, Tompkins C, Wood DL, Nadler PI, Kirkwood JM. Logan TF, et al. Among authors: wood dl. J Immunother. 1997 Sep;20(5):387-98. doi: 10.1097/00002371-199709000-00008. J Immunother. 1997. PMID: 9336746 Clinical Trial.

6

Therapy of genital herpes with topically applied interferon.

Eron LJ, Toy C, Salsitz B, Scheer RR, Wood DL, Nadler PI. Eron LJ, et al. Among authors: wood dl. Antimicrob Agents Chemother. 1987 Jul;31(7):1137-9. doi: 10.1128/AAC.31.7.1137. Antimicrob Agents Chemother. 1987. PMID: 3310870 Free PMC article. Clinical Trial.

7

Biologic response (antiviral) to recombinant human interferon alpha 2a as a function of dose and route of administration in healthy volunteers.

Witter F, Barouki F, Griffin D, Nadler P, Woods A, Wood D, Lietman P. Witter F, et al. Among authors: wood d. Clin Pharmacol Ther. 1987 Nov;42(5):567-75. doi: 10.1038/clpt.1987.198. Clin Pharmacol Ther. 1987. PMID: 2445516

8

Time course of interferon levels, antiviral state, 2',5'-oligoadenylate synthetase and side effects in healthy men.

Barouki FM, Witter FR, Griffin DE, Nadler PI, Woods A, Wood DL, Lietman PS. Barouki FM, et al. Among authors: wood dl. J Interferon Res. 1987 Feb;7(1):29-39. doi: 10.1089/jir.1987.7.29. J Interferon Res. 1987. PMID: 3035034

9

NCCN Guidelines® Insights: Lung Cancer Screening, Version 1.2025.

Wood DE, Kazerooni EA, Aberle DR, Argento C, Baines J, Boer B, Brown LM, Donington J, Eapen GA, Ferguson JS, Hou L, Klippenstein D, Kolansky AS, Kumar R, Leard LE, Leung ANC, Mazzone P, Merritt RE, Norris K, Onaitis M, Pipavath S, Puri V, Raz D, Reddy C, Reid ME, Sandler KL, Sands J, Schabath MB, Sears CR, Studts JL, Tanoue L, Thacker AL, Tong BC, Travis WD, Wei B, Westover K, McCullough B, Ramakrishnan S. Wood DE, et al. J Natl Compr Canc Netw. 2025 Jan;23(1):e250002. doi: 10.6004/jnccn.2025.0002. J Natl Compr Canc Netw. 2025. PMID: 39819601

10

Personalised estimation of exposure to ambient air pollution and application in a longitudinal cohort analysis of cognitive function in London-dwelling older adults.

Wood D, Evangelopoulos D, Kitwiroon N, Stewart G, Vu T, Smith J, Beevers S, Katsouyanni K. Wood D, et al. J Expo Sci Environ Epidemiol. 2025 Jan 14. doi: 10.1038/s41370-025-00745-7. Online ahead of print. J Expo Sci Environ Epidemiol. 2025. PMID: 39809977

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

4,997 results

Search Page

Filters